COCP
Cocrystal Pharma Inc
NASDAQ: COCP · HEALTHCARE · BIOTECHNOLOGY
$1.39
+0.00% today
Updated 2026-04-29
Market cap
$19.71M
P/E ratio
—
P/S ratio
92.45x
EPS (TTM)
$-0.78
Dividend yield
—
52W range
$1 – $2
Volume
3.0M
WallStSmart proprietary scores
24
out of 100
Grade: F
Strong Sell
Investment rating
5.7
Growth
C+5.0
Quality
C+3.0
Profitability
D6.7
Valuation
B—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →201 stocks currently score above 75
Price targets
Analyst target
$8.00
+475.54%
12-Month target
—
—
Intrinsic (DCF)
$5.32
Margin of safety
+82.06%
0 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Revenue growth 26.90% QoQ
+ 82.06% below intrinsic value
Risks
- Thin margins at 0.00%
- Negative free cash flow $-1.74M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $510000.00 |
| Net income | $-38.84M | $-17.98M | $-17.50M | $-8.83M | $-2.43M |
| EPS | — | — | — | — | $-0.78 |
| Free cash flow | $-21.51M | $-14.78M | $-16.49M | $-8.20M | $-1.74M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Cocrystal Pharma Inc trades at $1.39. Our Smart Value Score of 24/100 indicates the stock is weak. TTM revenue stands at $510000.00. Our DCF model estimates intrinsic value at $5.32.
Frequently asked questions
What is Cocrystal Pharma Inc's stock price?
Cocrystal Pharma Inc (COCP) trades at $1.39.
Is Cocrystal Pharma Inc overvalued?
Smart Value Score 24/100 (Grade F, Strong Sell). DCF value $5.32.
What is the price target of Cocrystal Pharma Inc (COCP)?
The analyst target price is $8.00, representing +475.5% upside from the current price of $1.39.
What is the intrinsic value of Cocrystal Pharma Inc (COCP)?
Based on our DCF model, intrinsic value is $5.32, a +82.1% margin of safety versus $1.39.
What is Cocrystal Pharma Inc's revenue?
TTM revenue is $510000.00.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio92.45x
ROE-111.40%
Beta1.18
50D MA$1.17
200D MA$1.22
Shares out0.01B
Float0.01B
Short ratio—
Avg volume3.0M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—